Amneal Pharmaceuticals, Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 58.68%50.90%43.08%21.70%31.54%36.73%35.47%34.28%36.52%
EBT Margin 21.10%16.57%-12.19%-13.54%-1.80%1.50%-11.22%-1.68%-1.97%
EBIT Margin 27.98%23.71%-1.18%-15.29%4.57%7.29%-4.29%8.54%8.92%
EBITDA Margin 27.98%23.71%-1.18%-15.29%4.57%7.29%-4.29%8.54%8.92%
Operating Margin 27.98%23.71%-1.18%-15.29%4.57%7.29%-4.29%8.54%8.92%
Net Margin 20.57%16.38%-1.26%-22.25%4.57%0.51%-5.88%-3.51%-4.18%
FCF Margin -0.76%13.49%10.05%-2.80%16.19%9.27%0.84%12.63%8.70%
Efficiency
Inventory Average 370.63M419.14M435.86M490.02M510.06M556.06M596.92M
Assets Average 2,847.31M4,009.31M3,835.96M3,972.85M3,869.50M3,635.95M3,487.01M
Equity Average -95.09M441.07M621.58M345.86M355.95M275.48M102.00M-44.75M
Invested Capital -175.94M1,430.21M3,548.41M2,977.31M3,124.42M3,077.64M2,805.92M2,440.14M2,276.49M
Asset Utilization Ratio 0.580.410.520.530.570.660.80
Leverage & Solvency
Debt to Equity -101.492.947.598.067.4314.41128.18-21.79
Debt Ratio 1.080.610.720.690.690.700.740.68
Equity Ratio -0.010.210.090.090.090.050.01-0.03
Dividends & Payouts
FCF Payout Ratio -26.072.691.09
Valuation
Enterprise Value -27.37M-64.01M4,217.83M1,290.47M1,040.26M1,213.25M603.12M1,810.47M2,408.39M
Market Capitalization 4,039.61M1,441.66M1,369.84M1,444.13M604.15M1,860.72M2,453.97M
Return Ratios
Return on Sales 0.21%0.16%-0.12%-0.37%0.03%0.01%-0.12%-0.02%-0.03%
Return on Capital Employed -0.01%-0.07%0.03%0.05%-0.03%0.07%0.11%
Return on Invested Capital 0.39%-0.01%0.03%
Return on Assets -0.07%-0.15%0.02%0.01%-0.07%-0.01%-0.02%
Return on Equity -1.78%-0.46%-0.97%0.20%0.06%-0.93%-0.48%1.65%